Framingham General Cardiovascular Risk Score and Cognitive Impairment: The Power of Foresight

Costantino Iadecola; Neal S Parikh

doi:10.1016/j.jacc.2020.03.061

Framingham General Cardiovascular Risk Score and Cognitive Impairment: The Power of Foresight

J Am Coll Cardiol. 2020 May 26;75(20):2535-2537. doi: 10.1016/j.jacc.2020.03.061.

Authors

Costantino Iadecola¹, Neal S Parikh²

Affiliations

¹ Feil Family Brain and Mind Research Institute, Clinical and Translational Neuroscience Unit, Weill Cornell Medicine, New York, New York; and the Department of Neurology, Weill Cornell Medicine, New York, New York. Electronic address: coi2001@med.cornell.edu.
² Feil Family Brain and Mind Research Institute, Clinical and Translational Neuroscience Unit, Weill Cornell Medicine, New York, New York; and the Department of Neurology, Weill Cornell Medicine, New York, New York.

No abstract available

Keywords: Framingham General Cardiovascular Risk Score; cognitive decline; cohort study; magnetic resonance imaging; neurodegeneration; vascular lesions.

Publication types

Editorial
Comment

MeSH terms

Brain
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Cognitive Dysfunction* / diagnosis
Cognitive Dysfunction* / epidemiology
Heart Disease Risk Factors
Humans
Risk Factors

Publication types

MeSH terms

Grants and funding